ITMCTR2200006003招募中未知
Survival Analysis after Hepatectomy for Hepatocellular Carcinoma: A Retrospective Cohort Study
Zhongshan Hospital Affiliated to Fudan University0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational study
入排标准
- 年龄范围
- 18 至 90(—)
- 性别
- All
入选标准
- •? It meets the diagnostic criteria of HCC and the characteristics of TCM syndrome differentiation and treatment; ? The general health status (PS) score is 0-2; ? Child Pugh is classified as a or B; ? The clinical stages of liver cancer in China (CNLC) are stage IA, stage IB, stage IIA and stage IIB; ? Radical treatment (Hepatectomy) after diagnosis of HCC is treatment measures and entered between December 2014 and may 2015; ? Postoperative TCM treatment mainly takes traditional Chinese medicine decoction (or granule); ? Postoperative medical treatment mainly included general medical treatment, transcatheter hepatic arterial chemoembolization (TACE) and systematic treatment; ? The original case data are relatively complete.
排除标准
- •? Those who do not have the conditions for radical treatment; ? Patients with serious adverse reactions after traditional Chinese medicine and traditional Chinese medicine treatment; ? Patients with invasion or extrahepatic metastasis; ? Severe basic liver disease or combined with other serious basic diseases (including other malignant tumors); ? Serious lack of original case data.
研究者
相似试验
已完成
不适用
A retrospective study of the outcome of hepatocellular carcinoma after liver resectiohepatocellular carcinomaJPRN-UMIN000045821ara Medical University278
招募中
不适用
Recurrence free survival after hepatectomy using propofol-based anesthesia and sevoflurane-based anesthesia: a randomized controlled studyKCT0004599Samsung Medical Center536
尚未招募
不适用
Resection of initially unresectable hepatocellular carcinoma with atezolizumab plus bevacizumab Additional study: Identification of biomarkers for predicting therapeutic effects and adverse eventsHepatocellular CarcinomaJPRN-UMIN000046634ational Center for Global Health and Medicine50
招募中
不适用
RACB StudyHepatocellular CarcinomaJPRN-jRCTs051210148Hatano Etsuro50
已完成
2 期
Randomised phase II study of postoperative hepatic arterial infusion chemotherapy (IFN/5-FU versus low-dose FP) for hepatocellular carcioma with portal vein tumor thrombus. (KHBO1207)Hepatocellular carcinomaJPRN-UMIN000010425Kansai Hepatobiliary Oncology Group (KHBO)66
